Log In
Print
BCIQ
Print
Print this Print this
 

MuGard

  Manage Alerts
Collapse Summary General Information
Company PlasmaTech Biopharmaceuticals Inc.
DescriptionMucoadhesive oral rinse
Molecular Target Undisclosed
Mechanism of ActionUndisclosed
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMucositis
Indication DetailsTreat oral mucositis (OM) in cancer patients
Regulatory Designation

Partner

AMAG Pharmaceuticals Inc.; Dong-A Pharmaceutical Co. Ltd.; Hanmi Pharmaceutical Co. Ltd.; Norgine B.V.; RHEI Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today